Compound ID | 2921
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Folate synthesis inhibitor. FabK inhibitor |
| Target Pathogen: | Active against Fusobacterium nucleatum (an oral pathobiont) and Streptococcus sp. |
| Description: | Synthetic compound; phenylimidazole analogue; no cytotoxicity towards mammalian cell lines at >100 ug/ml (highest tested) |
| Year first mentioned: | 2024 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://pubs.acs.org/doi/10.1021/acsinfecdis.3c00710 |